Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Some skin diseases and their treatments can negatively affect male fertility.

Hair changes can indicate systemic diseases or medication effects.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Low androgen levels can still cause female pattern hair loss.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

The document is a detailed medical reference on skin and genetic disorders.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

PCOS increases the risk of heart disease and type 2 diabetes in women.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Acyzol could help treat conditions caused by zinc deficiency.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.